Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Hyman

Showing results (1-10 of 174) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Tumor Genetic Screening Programs: A Call to ActionDavid M Hyman, David B Solit
JAMA|January 26, 2012
Unwrapping the implications of BRCA1 and BRCA2 mutations in ovarian cancerDavid M Hyman, David R Spriggs
Cancer Discovery|June 4, 2017
Quantifying the Benefits of Genome-Driven OncologyAlison M Schram, David M Hyman
Nature|November 15, 2019
A view on drug resistance in cancerNeil Vasan, José Baselga, David M Hyman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Picking the Right Patient for Human Epidermal Growth Factor Receptor 3-Targeted Therapy in Platinum-Resistant Ovarian CancerAlison M Schram, Alexia Iasonos, David M Hyman
Clinical Advances in Hematology & Oncology : H&O|June 14, 2014
Targeted therapies for treatment of recurrent ovarian cancerRachel N Grisham, David M Hyman, Gopa Iyer
Cell|February 11, 2017
Implementing Genome-Driven OncologyDavid M Hyman, Barry S Taylor, José Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Reply to M.P. Decatris et alDavid M Hyman, David B Solit, Alexia Iasonos
Current Opinion in Oncology|May 21, 2014
Management of advanced uterine leiomyosarcomaDavid M Hyman, Rachel N Grisham, Martee L Hensley
Oncology|October 12, 2011
Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: a case series and review of the literatureDavid M Hyman, Gerald A Soff, Lewis J Kampel
Pageof 18

Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Tumor Genetic Screening Programs: A Call to ActionDavid M Hyman, David B Solit
JAMA|January 26, 2012
Unwrapping the implications of BRCA1 and BRCA2 mutations in ovarian cancerDavid M Hyman, David R Spriggs
Cancer Discovery|June 4, 2017
Quantifying the Benefits of Genome-Driven OncologyAlison M Schram, David M Hyman
Nature|November 15, 2019
A view on drug resistance in cancerNeil Vasan, José Baselga, David M Hyman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Picking the Right Patient for Human Epidermal Growth Factor Receptor 3-Targeted Therapy in Platinum-Resistant Ovarian CancerAlison M Schram, Alexia Iasonos, David M Hyman
Clinical Advances in Hematology & Oncology : H&O|June 14, 2014
Targeted therapies for treatment of recurrent ovarian cancerRachel N Grisham, David M Hyman, Gopa Iyer
Cell|February 11, 2017
Implementing Genome-Driven OncologyDavid M Hyman, Barry S Taylor, José Baselga
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Reply to M.P. Decatris et alDavid M Hyman, David B Solit, Alexia Iasonos
Current Opinion in Oncology|May 21, 2014
Management of advanced uterine leiomyosarcomaDavid M Hyman, Rachel N Grisham, Martee L Hensley
Oncology|October 12, 2011
Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: a case series and review of the literatureDavid M Hyman, Gerald A Soff, Lewis J Kampel
Pageof 18